Brief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Thu 01:25
BRIEF-Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer Nov 12 (Reuters) - Alphamab Oncology 9966.HK:
FEI WANG RESIGNS AS CHIEF FINANCIAL OFFICER OF ALPHAMAB ONCOLOGY
APPOINTMENT OF DAVID NG AS CFO
Further company coverage: 9966.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)